MacroGenics | MGNX - Ebitda

Macrogenics reported $15.21M in EBITDA for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebitda Change
Amgen AMGN:US USD 3.04B 460M
AstraZeneca AZN:LN USD 3.32B 283M
Biogen BIIB:US USD 998.8M 6M
Bristol Myers Squibb BMY:US USD 4.66B 663M
Daiichi Sankyo 4568:JP JPY 47.64B 28.67B
Gilead Sciences GILD:US USD 2.7B 662M
Immunogen IMGN:US USD -59131000 17.87M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Macrogenics MGNX:US USD 15.21M 37.32M
Mirati Therapeutics MRTX:US USD -210832000 25.1M
Pfizer PFE:US USD 6.94B 3.94B
Puma Biotechnology PBYI:US USD 12.22M 7.6M
Roche Holding ROG:VX 10.43B 3B
Seattle Genetics SGEN:US USD -136103000 39.11M
Xencor XNCR:US USD -40434000 4.32M